Study: Bust the burgers, go nuts for reflux
By GREGORY ZELLER // This just in from the Insult to Injury Department: Victims of acid reflux can defeat the dreaded disorder without choking down a lifetime of pharmaceuticals –…
Kevin Tracey
ALZ: Genetic variants can run, but they can’t hide
The Feinstein Institute for Medical Research is targeting genetic risk factors behind Alzheimer’s disease, the first of many steps toward new potential treatments. Feinstein Institute assistant professor Yun Freudenberg-Hua has…
Feinstein researchers eye brain-tumor breakthrough
A common medication used to treat parasitic infections could leapfrog to the top of medical science’s brain-cancer arsenal. Pure scientific research funded by federal grants has led to this potential…
Northwell, drug-maker ink bioelectronics partnership
By GREGORY ZELLER // Bioelectronic medicine has taken another forward leap, thanks to the Feinstein Institute for Medical Research’s latest professional alliance. The research-and-development arm of the Northwell Health system…
Rockefeller researcher nabs Feinstein’s molecular prize
Advanced molecular-genetics studies have earned a Rockefeller University researcher accolades from the Feinstein Institute for Medical Research, and a fat check. While Feinstein Institute scientists are often the ones collecting…
GE brings good things to bioelectronics research
By GREGORY ZELLER // General Electric is giving the Feinstein Institute for Medical Research a bioelectronic jolt. The Feinstein Institute, R&D mecca of the Northwell Health system, announced a new…
Feinsteins donate $25M (again) to Northwell research
By GREGORY ZELLER // The Feinsteins have gone Bed, Bath & Beyond the call of duty, once again. Susan Feinstein and her husband, Leonard, co-founder and co-chairman of the New…
LI Bioscience Hub backs 10 in new funding round
By GREGORY ZELLER // A fresh batch of commercially promising biomedical innovations has been funded by the Long Island Bioscience Hub. The LIBH’s third round of grant awards – bestowed…
New veeps target Feinstein Institute growth
Hungry for growth, the Feinstein Institute for Medical Research has beefed up its administrative team. Following a year of groundbreaking research and ambitious business ventures, the bioelectronic medicine-friendly institute has…
Nerves of steel: Sanguistat stimulator steps up
By GREGORY ZELLER // The world’s leading cause of maternal deaths is the target of new clinical trials for a trailblazing bioelectronic medical device. The Neural Tourniquet, an electronic nerve-stimulation…
Centricity event highlights Feinstein heart, tech
By GREGORY ZELLER // The Feinstein Institute flexed its investigative muscle Nov. 10, highlighting the awesome breadth of its clinical research programs in a day-long symposium at its Manhasset headquarters….
Debrief: Scientifically, Kevin Tracey is all business
Fresh off keynoting an international symposium at the New York Academy of Sciences, bioelectronic medicine pioneer Kevin Tracey is (as usual) busily overseeing operations at the groundbreaking Feinstein Institute for…
Feinstein researchers nab major NIH awards
Two cutting-edge Feinstein Institute for Medical Research projects have been selected for an elite National Institutes of Health funding program. Kevin Tracey, the institute’s president and CEO, and Ping Wang,…
Study is big news for Vagus pioneer Tracey
By GREGORY ZELLER // Medical science has taken an enormous step toward “using electronics to replace drugs.” Kevin Tracey’s words sound downright science-fictional. And no, researchers cannot wave a medical…
Feinstein’s Tracey to head bioelectronics summit
Feinstein Institute chief and global bioelectronics pioneer Kevin Tracey will headline a September New York Academy of Science conference on bioelectronic medicine. Tracey, Feinstein’s president and CEO and the brains…